Cited by 21
The DOI matches its Crossref record.
Reduction in injection risk behaviors after implementation of a syringe services program, Miami, Florida
Bartholomew, Tyler S., Feaster, Daniel J., Patel, Hardik, Forrest, David W., Tookes, Hansel E.·2021·Journal of Substance Abuse Treatment
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Crossref · 10.1016/j.jsat.2021.108344
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, NSP may help mitigate SSTVI, as they reduce needle sharing and reuse of injection equipment while contributing to injection cessation [33–38].”
In the citing paper
“NSP mitigate needle sharing and reuse of injection equipment [34–38]”
In the citing paper
“In addition, NSP may help mitigate SSTVI, as they reduce needle sharing and reuse of injection equipment while contributing to injection cessation [33–38].”
In the citing paper
“In addition, NSP may help mitigate SSTVI, as they reduce needle sharing and reuse of injection equipment while contributing to injection cessation [33–38].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 52
- Abdul-Quader, 2013, Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: A systematic review, AIDS and Behavior, 17, 2878, 10.1007/s10461-013-0593-y · DOI
- Altice, 2003, Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users, Journal of Urban Health, 80, 416, 10.1093/jurban/jtg053 · DOI
- Ashford, 2018, Peer-delivered harm reduction and recovery support services: Initial evaluation from a hybrid recovery community drop-in center and syringe exchange program, Harm Reduction Journal, 15, 52, 10.1186/s12954-018-0258-2 · DOI
- Bachhuber, 2018, Description and outcomes of a buprenorphine maintenance treatment program integrated within Prevention Point Philadelphia, an urban syringe exchange program, Substance Abuse, 39, 167, 10.1080/08897077.2018.1443541 · DOI
- Ball, 2019, Sharing of injection drug preparation equipment is associated with HIV infection: A cross-sectional study, JAIDS Journal of Acquired Immune Deficiency Syndromes, 81, e99, 10.1097/QAI.0000000000002062 · DOI
- Bartholomew, 2020, Examining risk behavior and syringe coverage among people who inject drugs accessing a syringe services program: A latent class analysis, International Journal of Drug Policy, 78, 102716, 10.1016/j.drugpo.2020.102716 · DOI
- Bartholomew, 2020, Impact of routine opt-out HIV/HCV screening on testing uptake at a syringe services program: An interrupted time series analysis, International Journal of Drug Policy., 84, 102875, 10.1016/j.drugpo.2020.102875 · DOI
- Bluthenthal, 2007, Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients, Drug and Alcohol Dependence, 89, 214, 10.1016/j.drugalcdep.2006.12.035 · DOI
- Bluthenthal, 1998, Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, 505, 10.1097/00042560-199808150-00013 · DOI
- Bluthenthal, 2004, Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities, Addiction, 99, 1136, 10.1111/j.1360-0443.2004.00694.x · DOI
- Bluthenthal, 2007, Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users, Addiction, 102, 638, 10.1111/j.1360-0443.2006.01741.x · DOI
- Bogart, 2005, Sexual risk among injection drug users recruited from syringe exchange programs in California, Sexually Transmitted Diseases, 32, 27, 10.1097/01.olq.0000148294.83012.d0 · DOI
- Broz, 2014, Prevalence of HIV infection and risk behaviors among younger and older injecting drug users in the United States, 2009, AIDS and Behavior, 18, 284, 10.1007/s10461-013-0660-4 · DOI
- Bruneau, 2014, Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: A longitudinal study, Clinical Infectious Diseases, 58, 755, 10.1093/cid/cit938 · DOI
- Colledge, 2020, Profile and correlates of injecting-related injuries and diseases among people who inject drugs in Australia. Drug and Alcohol Dependence, 108267
- Coye, 2020, Hospital costs of injection drug use in Florida, Clinical Infectious Diseases., 72, 499, 10.1093/cid/ciaa823 · DOI
- Dasgupta, 2019, Injection practices and sexual behaviors among persons with diagnosed HIV infection who inject drugs — United States, 2015–2017, Vol. 68, 653
- Degenhardt, 2017, Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: A multistage systematic review, The Lancet Global Health, 5, e1192, 10.1016/S2214-109X(17)30375-3 · DOI
- Des Jarlais, D. C., Kerr, T., Carrieri, P., Feelemyer, J., & Arasteh, K. (2016). HIV infection among persons who inject drugs: Ending old epidemics and addressing new outbreaks. AIDS (London, England), 30(6), 815. · DOI
- Dickson-Gomez, 2020, Injection and sexual risk among people who use or inject drugs in Kampala, Uganda: An exploratory qualitative study, PLoS One, 15, 10.1371/journal.pone.0231969 · DOI
- Edeza, 2020, HIV pre-exposure prophylaxis for people who inject drugs: The context of co-occurring injection- and sexual-related HIV risk in the U.S. Northeast, Substance Use & Misuse, 55, 525, 10.1080/10826084.2019.1673419 · DOI
- Gibson, 2001, Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users, Aids, 15, 1329, 10.1097/00002030-200107270-00002 · DOI
- Hagan, 2000, Changes in injection risk behavior associated with participation in the Seattle needle-exchange program, Journal of Urban Health, 77, 369, 10.1007/BF02386747 · DOI
- Hagan, 2001, Sharing of drug preparation equipment as a risk factor for hepatitis C, American Journal of Public Health, 91, 42, 10.2105/AJPH.91.1.42 · DOI
- Harris, 2009, Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support, Journal of Biomedical Informatics, 42, 377, 10.1016/j.jbi.2008.08.010 · DOI · Paper page
- Hunter, 2018, Safe and unsafe spaces: Non-fatal overdose, arrest, and receptive syringe sharing among people who inject drugs in public and semi-public spaces in Baltimore City, International Journal of Drug Policy, 57, 25, 10.1016/j.drugpo.2018.03.026 · DOI
- Huo, 2007, Needle exchange and injection-related risk behaviors in Chicago: A longitudinal study, JAIDS Journal of Acquired Immune Deficiency Syndromes, 45, 108, 10.1097/QAI.0b013e318050d260 · DOI
- Huo, 2009, Needle exchange and sexual risk behaviors among a cohort of injection drug users in Chicago, Illinois, Sexually Transmitted Diseases, 36, 35, 10.1097/OLQ.0b013e318186dee3 · DOI
- Kåberg, 2020, Significant decrease in injection risk behaviours among participants in a needle exchange programme, Infectious Diseases, 52, 336, 10.1080/23744235.2020.1727002 · DOI
- Knol, 2012, Overestimation of risk ratios by odds ratios in trials and cohort studies: Alternatives to logistic regression, Cmaj, 184, 895, 10.1503/cmaj.101715 · DOI
- Kral, 2004, Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies, JAIDS Journal of Acquired Immune Deficiency Syndromes, 37, 1307, 10.1097/01.qai.0000127054.60503.9a · DOI
- Larney, 2017, A systematic review of injecting-related injury and disease among people who inject drugs, Drug and Alcohol Dependence, 171, 39, 10.1016/j.drugalcdep.2016.11.029 · DOI · Paper page
- Marshall, 2010, Public injecting and HIV risk behaviour among street-involved youth, Drug and Alcohol Dependence, 110, 254, 10.1016/j.drugalcdep.2010.01.022 · DOI
- Mateu-Gelabert, 2020, Prescription opioid injection among young people who inject drugs in New York City: A mixed-methods description and associations with hepatitis C virus infection and overdose, Harm Reduction Journal, 17, 22, 10.1186/s12954-020-00367-2 · DOI
- Mir, 2018, A meta-analysis of the association between needle exchange programs and HIV seroconversion among injection drug users, Cureus, 10
- Neaigus, 2013, Dual HIV risk: Receptive syringe sharing and unprotected sex among HIV-negative injection drug users in New York City, AIDS and Behavior, 17, 2501, 10.1007/s10461-013-0496-y · DOI
- Nelson, 2011, Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews, Lancet, 378, 571, 10.1016/S0140-6736(11)61097-0 · DOI
- Noroozi, 2015, Client-level coverage of needle and syringe program and high-risk injection behaviors: A case study of people who inject drugs in Kermanshah, Iran, Addiction & Health, 7, 164
- O’Keefe, 2018, Measuring individual-level needle and syringe coverage among people who inject drugs in Myanmar, International Journal of Drug Policy, 58, 22, 10.1016/j.drugpo.2018.04.010 · DOI
- Palmateer, 2014, Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions, In PLoS One, 9, 10.1371/journal.pone.0104515 · DOI
- Reif, 2017, State of HIV in the US Deep South, Journal of Community Health, 42, 844, 10.1007/s10900-017-0325-8 · DOI
- Reif, 2014, HIV/AIDS in the Southern USA: A disproportionate epidemic, AIDS Care, 26, 351, 10.1080/09540121.2013.824535 · DOI
- Schulkind, 2019, High response and re-infection rates among people who inject drugs treated for hepatitis C in a community needle and syringe programme, Journal of Viral Hepatitis, 26, 519, 10.1111/jvh.13035 · DOI
- Small, 2007, Public injection settings in Vancouver: Physical environment, social context and risk, International Journal of Drug Policy, 18, 27, 10.1016/j.drugpo.2006.11.019 · DOI
- Spielberg, 2003, Overcoming barriers to HIV testing: Preferences for new strategies among clients of a needle exchange, a sexually transmitted disease clinic, and sex venues for men who have sex with men, JAIDS-HAGERSTOWN MD, 32, 318
- Spiller, 2015, HIV infection and HIV-associated behaviors among persons who inject drugs — 20 cities, United States, 2012, Vol. 64, 270
- Strathdee, 2013, Reductions in HIV/STI incidence and sharing of injection equipment among female sex workers who inject drugs: Results from a randomized controlled trial, PLoS One, 8, 10.1371/journal.pone.0065812 · DOI
- Strathdee, 1999, Needle-exchange attendance and health care utilization promote entry into detoxification, Journal of Urban Health, 76, 448, 10.1007/BF02351502 · DOI
- Strathdee, 2006, Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial, Drug and Alcohol Dependence, 83, 225, 10.1016/j.drugalcdep.2005.11.015 · DOI
- Trayner, 2019, Increased risk of HIV and other drug-related harms associated with injecting in public places among people who inject drugs in Scotland: A national bio-behavioural survey, The Lancet, 394, S91, 10.1016/S0140-6736(19)32888-0 · DOI
- Wejnert, 2016, Vital signs: Trends in HIV diagnoses, risk behaviors, and prevention among persons who inject drugs - United States, MMWR Morb Mortal Wkly Rep, 65, 1336, 10.15585/mmwr.mm6547e1 · DOI
- Zibbell, 2018, Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014, American Journal of Public Health, 108, 175, 10.2105/AJPH.2017.304132 · DOI
Cited by
Sorted by citations
Lim, J., Russell, W. A., El-Sheikh, M., Buckeridge, D. L., & Panagiotoglou, D. (2024) · Harm Reduction Journal · doi:10.1186/s12954-024-01037-3 · Cited by 3
Metadata
- Authors
- Bartholomew, T. S., Feaster, D. J., Patel, H., Forrest, D. W., & Tookes, H. E.
- Venue
- Journal of Substance Abuse Treatment
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 127
- Pages
- 108344
- ISSN
- 0740-5472
- PMC
- PMC8221088
- Cited by
- 21
- References
- 0
- Language
- en
- Licence
- Funders
- National Institute of Mental Health (P30MH116867)
- National Institute on Drug Abuse (R01DA045713, UG1DA13720)
- National Cancer Institute (P30CA240139)
- National Institutes of Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
